title: Hyperprolactinaemia on depot risperidone treated with aripiprazole.
authors.forename: Tharani
authors.initials: T
authors.lastname: Anandarajan
authors.forename: Prashant
authors.initials: P
authors.lastname: Tibrewal
authors.forename: Rohan
authors.initials: R
authors.lastname: Dhillon
authors.forename: Tarun
authors.initials: T
authors.lastname: Bastiampillai
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D000068180:Aripiprazole; D003692:Delayed-Action Preparations / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D016903:Drug Monitoring; D057915:Drug Substitution / Q000379:methods*; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced / Q000628:therapy; D054539:Medication Therapy Management; D060735:Pharmacovigilance; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D015363:Quinolones / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D018967:Risperidone / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D012559:Schizophrenia / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole; D018967:Risperidone